GB201209986D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB201209986D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2012-06-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1209986.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Autifony Therapeutics Ltd

Original Assignee

Autifony Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-06

Filing date

2012-06-06

Publication date

2012-07-18

2012-06-06 Priority to GBGB1209986.7A priority Critical patent/GB201209986D0/en

2012-06-06 Application filed by Autifony Therapeutics Ltd filed Critical Autifony Therapeutics Ltd

2012-06-07 Priority to CN201280027811.XA priority patent/CN103596943B/en

2012-06-07 Priority to US14/124,516 priority patent/US9193704B2/en

2012-06-07 Priority to JP2014514148A priority patent/JP6008953B2/en

2012-06-07 Priority to EP12726849.8A priority patent/EP2718285B1/en

2012-06-07 Priority to BR112013031402A priority patent/BR112013031402A2/en

2012-06-07 Priority to PCT/GB2012/051278 priority patent/WO2012168710A1/en

2012-07-18 Publication of GB201209986D0 publication Critical patent/GB201209986D0/en

2013-05-22 Priority to CN201380026712.4A priority patent/CN104334548A/en

2013-05-22 Priority to BR112014028718A priority patent/BR112014028718A2/en

2013-05-22 Priority to US14/403,011 priority patent/US9669030B2/en

2013-05-22 Priority to PCT/GB2013/051343 priority patent/WO2013175211A1/en

2013-05-22 Priority to EP13725443.9A priority patent/EP2852588B8/en

2013-05-22 Priority to JP2015513268A priority patent/JP2015517563A/en

2013-06-06 Priority to PCT/GB2013/051487 priority patent/WO2013182850A1/en

2013-06-06 Priority to PCT/GB2013/051488 priority patent/WO2013182851A1/en

2014-10-29 Priority to IN2409KON2014 priority patent/IN2014KN02409A/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB1209986.7A 2011-06-07 2012-06-06 Novel compounds Ceased GB201209986D0 (en)

Priority Applications (16)

Application Number	Priority Date	Filing Date	Title
GBGB1209986.7A GB201209986D0 (en)	2012-06-06	2012-06-06	Novel compounds
CN201280027811.XA CN103596943B (en)	2011-06-07	2012-06-07	Hydantoin derivatives useful as KV3 inhibitors
US14/124,516 US9193704B2 (en)	2011-06-07	2012-06-07	Hydantoin derivatives as KV3 inhibitors
JP2014514148A JP6008953B2 (en)	2011-06-07	2012-06-07	Hydantoin derivatives as KV3 inhibitors
EP12726849.8A EP2718285B1 (en)	2011-06-07	2012-06-07	Hydantoin derivatives as kv3 inhibitors
BR112013031402A BR112013031402A2 (en)	2011-06-07	2012-06-07	hydantoin derivatives as kv3 inhibitors
PCT/GB2012/051278 WO2012168710A1 (en)	2011-06-07	2012-06-07	Hydantoin derivates as kv3 inhibitors
CN201380026712.4A CN104334548A (en)	2012-05-22	2013-05-22	Hydantoin derivatives as kv3 inhibitors
JP2015513268A JP2015517563A (en)	2012-05-22	2013-05-22	Hydantoin derivatives as KV3 inhibitors
BR112014028718A BR112014028718A2 (en)	2012-05-22	2013-05-22	hydantoin derivatives as kv3 inhibitors
US14/403,011 US9669030B2 (en)	2012-05-22	2013-05-22	Hydantoin derivatives as Kv3 inhibitors
PCT/GB2013/051343 WO2013175211A1 (en)	2012-05-22	2013-05-22	Hydantoin derivatives as kv3 inhibitors
EP13725443.9A EP2852588B8 (en)	2012-05-22	2013-05-22	Hydantoin derivatives as kv3 inhibitors
PCT/GB2013/051487 WO2013182850A1 (en)	2012-06-06	2013-06-06	Isobenzofuran- 5 -yl-oxy- (hetero) aryl - imidazolidine - 2, 4 -dione derivatives modulators of kv3 potassium channels for the treatment of cns disorders.
PCT/GB2013/051488 WO2013182851A1 (en)	2012-06-06	2013-06-06	Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required
IN2409KON2014 IN2014KN02409A (en)	2012-05-22	2014-10-29

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1209986.7A GB201209986D0 (en)	2012-06-06	2012-06-06	Novel compounds

Publications (1)

Publication Number	Publication Date
GB201209986D0 true GB201209986D0 (en)	2012-07-18

Family

ID=46582363

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1209986.7A Ceased GB201209986D0 (en)	2011-06-07	2012-06-06	Novel compounds

Country Status (2)

Country	Link
GB (1)	GB201209986D0 (en)
WO (1)	WO2013182850A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6008953B2 (en)	2011-06-07	2016-10-19	アウトイフオンイトヘラペウトイクスリミテッド	Hydantoin derivatives as KV3 inhibitors
US9422252B2 (en)	2012-05-22	2016-08-23	Autifony Therapeutics Limited	Triazoles as Kv3 inhibitors
US9669030B2 (en)	2012-05-22	2017-06-06	Autifony Therapeutics Limited	Hydantoin derivatives as Kv3 inhibitors
GB201521751D0 (en)	2015-12-10	2016-01-27	Autifony Therapeutics Ltd	Novel uses
IL282096B2 (en)	2018-10-16	2024-07-01	Autifony Therapeutics Ltd	History of 3-[5-[(3,3-dialkyl-2H-benzofuran-4-yl]oxy]pyrazin-2-yl]-5,5-dialkyl-imidazolidine-2,4-dione and pharmaceutical preparations containing them
CN113710318A (en) *	2019-04-26	2021-11-26	H.隆德贝克有限公司	Arylsulfonyl thiophenecarboxamides and arylsulfonyl furancarboxamides as Kv3 potassium channel activators
MX2022009702A (en)	2020-02-06	2022-09-07	Autifony Therapeutics Ltd	Kv3 modulators.
JP2024530208A (en)	2021-08-10	2024-08-16	アウトイフオンイトヘラペウトイクスリミテッド	Potassium Channel Modulators
WO2024121552A1 (en)	2022-12-06	2024-06-13	Autifony Therapeutics Limited	Compounds for the treatment of centra nervous system disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112012015868A2 (en)	2009-12-11	2017-06-20	Autifony Therapeutics Ltd	imidazolidinedione derivatives
EP2649066B1 (en)	2010-12-06	2015-10-21	Autifony Therapeutics Limited	Hydantoin derivatives useful as kv3 inhibitors
JP6008953B2 (en)	2011-06-07	2016-10-19	アウトイフオンイトヘラペウトイクスリミテッド	Hydantoin derivatives as KV3 inhibitors

2012
- 2012-06-06 GB GBGB1209986.7A patent/GB201209986D0/en not_active Ceased
2013
- 2013-06-06 WO PCT/GB2013/051487 patent/WO2013182850A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2013182850A1 (en)	2013-12-12

Publication	Publication Date	Title
SG11201406274VA (en)	2014-11-27	Novel compounds
GB201207406D0 (en)	2012-06-13	Novel compounds
SG10201703484YA (en)	2017-06-29	Novel compounds
IL238800A0 (en)	2015-06-30	Novel compounds
GB201212871D0 (en)	2012-09-05	Novel compounds
GB201209986D0 (en)	2012-07-18	Novel compounds
IL280595A (en)	2021-03-25	Novel compounds
GB201222711D0 (en)	2013-01-30	Novel compounds
GB201207392D0 (en)	2012-06-13	Novel compounds
GB201209670D0 (en)	2012-07-18	Novel compounds
GB201212816D0 (en)	2012-09-05	Novel compounds
GB201222435D0 (en)	2013-01-23	Novel compounds
GB201222433D0 (en)	2013-01-23	Novel compounds
GB201222430D0 (en)	2013-01-23	Novel compounds
GB201222419D0 (en)	2013-01-23	Novel compounds
GB201222393D0 (en)	2013-01-23	Novel compounds
GB201219554D0 (en)	2012-12-12	Novel compounds
GB201219472D0 (en)	2012-12-12	Novel compounds
GB201217387D0 (en)	2012-11-14	Novel compounds
GB201216551D0 (en)	2012-10-31	Novel compounds
GB201216548D0 (en)	2012-10-31	Novel compounds
GB201213023D0 (en)	2012-09-05	Novel compounds
GB201211246D0 (en)	2012-08-08	Novel compounds
GB201209020D0 (en)	2012-07-04	Novel compounds
GB201209013D0 (en)	2012-07-04	Novel compounds

Legal Events

Date	Code	Title	Description
2013-12-04	AT	Applications terminated before publication under section 16(1)